569 related articles for article (PubMed ID: 19536938)
21. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
Siddiqi A; Payne AG; Zafar S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
[TBL] [Abstract][Full Text] [Related]
22. A physician discusses the dental impact of oral bisphosphonates.
Roudebush CP
J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
[No Abstract] [Full Text] [Related]
23. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
McLeod NM; Davies BJ; Brennan PA
Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
26. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; MaurÃcio AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
27. [Bisphosphonate-related osteonecrosis of the jaw].
Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
[TBL] [Abstract][Full Text] [Related]
28. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
Savoldelli C; Le Page F; Santini J; Scortecci G; Odin G
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
[TBL] [Abstract][Full Text] [Related]
29. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review.
Silverman SL; Landesberg R
Am J Med; 2009 Feb; 122(2 Suppl):S33-45. PubMed ID: 19187811
[TBL] [Abstract][Full Text] [Related]
30. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
31. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.
Dunstan CR; Felsenberg D; Seibel MJ
Nat Clin Pract Oncol; 2007 Jan; 4(1):42-55. PubMed ID: 17183355
[TBL] [Abstract][Full Text] [Related]
32. [Osteonecrosis of the jaw and bisphophonates in oncology].
Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A
Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570
[TBL] [Abstract][Full Text] [Related]
33. Osteonecrosis of the jaw.
Sambrook PN; Ebeling P
Curr Rheumatol Rep; 2008 Apr; 10(2):97-101. PubMed ID: 18460263
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonates and oral pathology I. General and preventive aspects.
Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
36. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
[TBL] [Abstract][Full Text] [Related]
37. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
[TBL] [Abstract][Full Text] [Related]
38. Dental endosseous implants in patients on bisphosphonate therapy.
Scully C; Madrid C; Bagan J
Implant Dent; 2006 Sep; 15(3):212-8. PubMed ID: 16966893
[TBL] [Abstract][Full Text] [Related]
39. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
Cremers S; Farooki A
Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
[TBL] [Abstract][Full Text] [Related]
40. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
